Benjamin Berinson
bacteriarast.bsky.social
Benjamin Berinson
@bacteriarast.bsky.social
Clinical microbiologist, impact of rapid ID and AST
Reposted by Benjamin Berinson
In moderate to low quality observational data, cefazolin was non-inferior for mortality and potentially superior for safety as compared to antistaphylococcal penicillins overall and across most individual comparisons
May 9, 2025 at 9:55 AM
Reposted by Benjamin Berinson
Family reunion 🥰

Can you spot our 3 new members ? 🐥🐥🐥

@yousrakherabi.bsky.social @listeriacolectiva.bsky.social @effemedioli.bsky.social

@escmid.bsky.social
April 11, 2025 at 12:21 PM
Finally published! Our prospective evaluation of the performance and clinical impact of the Biofire Joint Infection Panel.

Congrats to all the co-authors looking forward to future collaborations!

journals.asm.org/doi/10.1128/...
Prospective evaluation of real-world performance and clinical impact of the Biofire FilmArray joint infection panel | Microbiology Spectrum
Pathogen detection is critical for targeted management of joint infections; however, cultural detection of pathogens can be challenging. The Biofire Joint Infection Assay (BJA) is a syndromic panel PC...
journals.asm.org
February 25, 2025 at 11:54 PM
Reposted by Benjamin Berinson
Cefiderocol susceptibility testing is challenging as none of the commercial tests have been proven to accurately determine the susceptibility in the area of technical uncertainty (ATU)
🆕💫Study : Performance of different FDC testing methods on KP in ATU range #idsky
academic.oup.com/jac/advance-...
Cefiderocol AST in a real-life Klebsiella pneumoniae collection: challenges in the ATU range
AbstractObjectives. FDC susceptibility testing is challenging as none of the commercial tests have been proven to accurately determine the susceptibility i
academic.oup.com
January 15, 2025 at 10:44 AM